Ramantamig
Ramantamig is a humanized monoclonal antibody targeting human CD3ε, GPRC5D, and TNFRSF17 (tumor necrosis factor receptor superfamily member 17) 。Ramantamig is promising for research of cancers, especially hematological malignancies such as multiple myeloma[1].
Product Specifications
CAS Number
[2988886-91-3]
Product Name Alternative
JNJ-79635322; JNJ-5322
UNSPSC
12352203
Target
CD3; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
